BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 10300504)

  • 1. The future of Medicare capital reimbursement.
    Teach R
    Cost Containment; 1985 Sep; 7(18):3-6. PubMed ID: 10300504
    [No Abstract]   [Full Text] [Related]  

  • 2. Data, analysis and policy options. Medicare payment of hospital capital-related costs.
    Rubin RJ; Helms RB
    Healthc Financ Manage; 1984 Apr; 38(4):21-8. PubMed ID: 10315525
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of capital payment options under Medicare prospective payment. An ECRI technology management assessment.
    J Health Care Technol; 1986; 2(4):231-46. PubMed ID: 10300810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing present and future capital expense levels under PPS.
    Cleverley WO
    Healthc Financ Manage; 1986 Sep; 40(9):62-72. PubMed ID: 10300940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The debate over capital costs.
    Robinson ML
    Healthspan; 1986 Mar; 3(3):15-23. PubMed ID: 10300722
    [No Abstract]   [Full Text] [Related]  

  • 6. Capital reimbursement and health planning: more than a matter of cost-containment.
    Abernethy D
    Health Manage Q; 1984; ():2-5. PubMed ID: 10299739
    [No Abstract]   [Full Text] [Related]  

  • 7. Quayle spurs capital payment reform. Interview by Michael Lesparre.
    Quayle D
    Hospitals; 1986 Feb; 60(3):62-3. PubMed ID: 3510959
    [No Abstract]   [Full Text] [Related]  

  • 8. Suits over capital payments? Maybe..
    Burda D
    Hospitals; 1986 Jun; 60(12):31-2. PubMed ID: 3519425
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial management. Reimbursement of capital costs.
    Grimaldi PL
    Nurs Manage; 1983 Dec; 14(12):61-4. PubMed ID: 6419187
    [No Abstract]   [Full Text] [Related]  

  • 10. Capital payment under PPS: can hospitals still bloom?
    Nash D; Haught JA; Hopkins A; Oxler K; Rovinsky M
    Healthc Financ Manage; 1986 Apr; 40(4):29-37. PubMed ID: 10300594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A securities analyst views capital cost reimbursement.
    Gargiulo GT
    Health Manage Q; 1984; ():6-9. PubMed ID: 10273589
    [No Abstract]   [Full Text] [Related]  

  • 12. What's the controversy behind capital payment under prospective pricing?
    Warner G
    Trustee; 1984 Sep; 37(9):39-40. PubMed ID: 10273576
    [No Abstract]   [Full Text] [Related]  

  • 13. The three components of a prospective capital reimbursement system.
    Neumann BR; Kelly JV
    Healthc Financ Manage; 1984 Jul; 38(7):92-100. PubMed ID: 10315580
    [No Abstract]   [Full Text] [Related]  

  • 14. Tracking capital costs by product line is key.
    Riffer J
    Hospitals; 1986 Jun; 60(12):68. PubMed ID: 3710453
    [No Abstract]   [Full Text] [Related]  

  • 15. Financial tools in evaluating profit and DRG cost determination.
    Wilson CN
    Hosp Pharm; 1984 Oct; 19(10):703-5. PubMed ID: 10273580
    [No Abstract]   [Full Text] [Related]  

  • 16. Exploring the options of Medicare payment for capital.
    Warner G
    Hospitals; 1984 Mar; 58(6):66-7. PubMed ID: 6365731
    [No Abstract]   [Full Text] [Related]  

  • 17. Medicare payment for capital.
    Kovener RR; Herr WW
    Rev Fed Am Health Syst; 1990; 23(3):12, 14-6. PubMed ID: 10106713
    [No Abstract]   [Full Text] [Related]  

  • 18. Equipment acquisition under prospective pricing.
    Goodhart M
    Hosp Cap Finance; 1985; 2(4):7-8. PubMed ID: 10274580
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective payment for capital: the financial nature of capital allowances.
    Krystynak LF
    Healthc Financ Manage; 1983 Oct; 37(10):60-8, 74-6. PubMed ID: 10315440
    [No Abstract]   [Full Text] [Related]  

  • 20. Capital strategies combat the removal of PIP.
    McCue MJ; Camp RC
    Healthc Financ Manage; 1987 Sep; 41(9):112-4. PubMed ID: 10301857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.